A Phase II Trial Of Autologous Stem Cell Transplant Followed By Mini-Allogeneic Stem Cell Transplant In Lieu Of Standard Allogeneic Bone Marrow Transplantation For Treatment Of Multiple Myeloma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ciclosporin; Cyclophosphamide; Fludarabine; Melphalan
- Indications Graft-versus-host disease; Multiple myeloma
- Focus Therapeutic Use
- 02 Jan 2019 Biomarkers information updated
- 25 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Nov 2008 Last checked against ClinicalTrials.gov record.